IMM News: Immutep (IMMP) Up on Initial Data From Lung Cancer Study - 26th May 2023, 5:16am

[annb0t]

Immutep Limited’s IMMP shares surged 6.5% on May 24, after it announced encouraging data from a third arm of the phase I INSIGHT study called INSIGHT-003. The study is being evaluated in the combination use of its lead pipeline candidate, eftilagimod alpha (“efti”), in the first-line (“1L”) non-small cell lung cancer (“NSCLC”).

INSIGHT-003 is a triple combination study of efti, Merck’s MRK blockbuster anti-PD-1 therapy Keytruda (pembrolizumab) and c...

>>> Read more: Immutep (IMMP) Up on Initial Data From Lung Cancer Study